Pharmena S.A. (WSE: PHR)
Poland
· Delayed Price · Currency is PLN
4.840
-0.010 (-0.21%)
Nov 21, 2024, 1:22 PM CET
Pharmena Revenue
Pharmena had revenue of 148.00K PLN in the quarter ending June 30, 2024, with 1,133.33% growth. This brings the company's revenue in the last twelve months to 291.00K, down -4.28% year-over-year. In the year 2023, Pharmena had annual revenue of 299.00K.
Revenue (ttm)
291.00K
Revenue Growth
-4.28%
P/S Ratio
185.63
Revenue / Employee
19.40K
Employees
15
Market Cap
54.02M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 299.00K | - | - |
Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
Dec 31, 2020 | 9.93M | -1.17M | -10.51% |
Dec 31, 2019 | 11.10M | -1.94M | -14.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.14B |
NEUCA S.A. | 12.34B |
Sopharma AD | 4.35B |
Synektik Spólka Akcyjna | 618.67M |
Celon Pharma S.A. | 206.81M |
Voxel S.A. | 476.19M |
Ryvu Therapeutics S.A. | 91.18M |
Selvita S.A. | 329.02M |